TY - JOUR
T1 - Renal handling of tobramycin in the isolated perfused rat kidney
AU - Aiba, Tetsuya
AU - Itoga, Yoshie
AU - Shimizu, Hiromasa
AU - Tanigawara, Yusuke
AU - Hori, Ryohei
PY - 1994/5
Y1 - 1994/5
N2 - The renal handling of tobramycin (TOB), an aminoglycoside antibiotic (AG), was studied using a single‐pass isolated perfused rat kidney with moment analysis. In the bolus administration study at tracer concentration (7.4 μM), 32% of the glomerular‐filtrated TOB remained in the lumen, but no TOB was found in the vein. This ratio of the luminal uptake was reduced in a dose‐dependent manner. Other aminoglycosides such as gentamicin inhibited this uptake, but tetraethylammonium and glucosamine had no effect. In addition, under the alkalinuria condition, TOB uptake was decreased to 67% of the control value. This indicated that TOB has mainly been taken into the renal epithelial cells from their luminal site and that this uptake process was saturable and specific for AGs which have more than one cationic group. The present findings should be helpful in developing a method to reduce the nephrotoxicity of AGs and to identify their toxicity mechanisms.
AB - The renal handling of tobramycin (TOB), an aminoglycoside antibiotic (AG), was studied using a single‐pass isolated perfused rat kidney with moment analysis. In the bolus administration study at tracer concentration (7.4 μM), 32% of the glomerular‐filtrated TOB remained in the lumen, but no TOB was found in the vein. This ratio of the luminal uptake was reduced in a dose‐dependent manner. Other aminoglycosides such as gentamicin inhibited this uptake, but tetraethylammonium and glucosamine had no effect. In addition, under the alkalinuria condition, TOB uptake was decreased to 67% of the control value. This indicated that TOB has mainly been taken into the renal epithelial cells from their luminal site and that this uptake process was saturable and specific for AGs which have more than one cationic group. The present findings should be helpful in developing a method to reduce the nephrotoxicity of AGs and to identify their toxicity mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0028341705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028341705&partnerID=8YFLogxK
U2 - 10.1002/jps.2600830526
DO - 10.1002/jps.2600830526
M3 - Article
C2 - 8071829
AN - SCOPUS:0028341705
SN - 0022-3549
VL - 83
SP - 723
EP - 726
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
IS - 5
ER -